-->

Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
SC 13D/AAmendment to a SC 13D filingJul 31, 2009View HTMLDownload DOCDownload PDFDownload XLS
SC 13D/AAmendment to a SC 13D filingJun 24, 2009View HTMLDownload DOCDownload PDFDownload XLS
SC 13D/AAmendment to a SC 13D filingJun 19, 2009View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GApr 21, 2009View HTMLDownload DOCDownload PDF
SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5%Apr 13, 2009View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderMar 27, 2009View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GMar 10, 2009View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsMar 6, 2009View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 17, 2009View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2009View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 12, 2009View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 12, 2009View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 5, 2009View HTMLDownload DOCDownload PDFDownload XLS
SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5%Jan 30, 2009View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GJan 7, 2009View HTMLDownload DOCDownload PDFDownload XLS

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information